2-((E)-4-(4-Bromophenyl)-1-hydroxybut-3-enyl)-1,4-dihydroxyanthracene-9,10-dione

ID: ALA3797654

Chembl Id: CHEMBL3797654

PubChem CID: 127047744

Max Phase: Preclinical

Molecular Formula: C24H17BrO5

Molecular Weight: 465.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2ccccc2C(=O)c2c(O)c(C(O)C/C=C/c3ccc(Br)cc3)cc(O)c21

Standard InChI:  InChI=1S/C24H17BrO5/c25-14-10-8-13(9-11-14)4-3-7-18(26)17-12-19(27)20-21(24(17)30)23(29)16-6-2-1-5-15(16)22(20)28/h1-6,8-12,18,26-27,30H,7H2/b4-3+

Standard InChI Key:  NQLJMMARAKQSAN-ONEGZZNKSA-N

Alternative Forms

  1. Parent:

    ALA3797654

    ---

Associated Targets(Human)

MCF10 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.30Molecular Weight (Monoisotopic): 464.0259AlogP: 4.77#Rotatable Bonds: 4
Polar Surface Area: 94.83Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.51CX Basic pKa: CX LogP: 6.30CX LogD: 6.26
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: 0.84

References

1. Zhao LM, Cao FX, Jin HS, Zhang JH, Szwaya J, Wang G..  (2016)  One-pot synthesis of 1,4-dihydroxy-2-((E)-1-hydroxy-4-phenylbut-3-enyl)anthracene-9,10-diones as novel shikonin analogs and evaluation of their antiproliferative activities.,  26  (11): [PMID:27080175] [10.1016/j.bmcl.2016.04.006]

Source